Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
iFrontier is a South Korean life science solution provider that specializes in the distribution of laboratory reagents, instruments, and bioinformatics services. Founded in 2000, the company established itself as a leader in the Korean bioinformatics market before being acquired by Macrogen in 2004. Today, it operates as a key subsidiary of Macrogen, serving as a major distributor for global life science brands such as Thermo Fisher Scientific (including Applied Biosystems, Invitrogen, and Gibco). The company provides comprehensive support for genomic research, including technical consulting and specialized software solutions for biological data analysis. iFrontier plays a critical role in the South Korean biotech ecosystem by bridging international technology providers with local academic and industrial research institutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on iFrontier.